GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AK Medical Holdings Ltd (HKSE:01789) » Definitions » Research & Development

AK Medical Holdings (HKSE:01789) Research & Development : HK$150 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is AK Medical Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. AK Medical Holdings's Research & Development for the six months ended in Dec. 2023 was HK$77 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was HK$150 Mil.


AK Medical Holdings Research & Development Historical Data

The historical data trend for AK Medical Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AK Medical Holdings Research & Development Chart

AK Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.61 124.44 138.45 123.81 149.99

AK Medical Holdings Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.10 63.77 63.06 72.55 77.44

AK Medical Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$150 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AK Medical Holdings  (HKSE:01789) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


AK Medical Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of AK Medical Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


AK Medical Holdings (HKSE:01789) Business Description

Traded in Other Exchanges
N/A
Address
No. 10 Baifuquan Road, 2nd Floor, Xingye Mansion, Changping District Science and Technology Park, Beijing, CHN, 102200
AK Medical Holdings Ltd is an investment holding company which designs, develops, produces, and markets orthopedic joint implants and related products. The company's geographical segments include China and the United Kingdom. It derives the majority of revenue from China. The company offers off-the-shelf products, such as knee replacement and hip replacement implants; and 3D-printed products, including 3D-printed hip replacement implants, spinal interbody cages, and artificial vertebral bodies.

AK Medical Holdings (HKSE:01789) Headlines

No Headlines